Crossmark

Is robotic da Vinci Xi® superior to the da Vinci Si® for sphincter-preserving total mesorectal excision? Outcomes in 150 mid-low rectal cancer patients

Crossref DOI link: https://doi.org/10.1007/s11701-021-01356-8

Published Online: 2022-02-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aliyev, Vusal

Arslan, Naciye Cigdem

Goksoy, Beslen

Guven, Koray

Goksel, Suha

Asoglu, Oktar https://orcid.org/0000-0002-9147-1654
License Information

Text and Data Mining valid from 2022-02-02

Version of Record valid from 2022-02-02
More Information

Article History

Received: 18 November 2021

Accepted: 12 December 2021

First Online: 2 February 2022

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose. Author Vusal Aliyev, Author Naciye Cigdem Arslan, Author Beslen Goksoy, Author Koray Guven, Author Suha Goksel and Author Oktar Asoglu declare that they have no conflict of interest.

: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below